OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GRG1L.VL50

Grigeo Group AB

Personal ProductsVerified

Grigeo Group AB has a fully diluted share count of 132,820,000, matching its basic share count, indicating no dilution from stock options or convertible instruments. However, liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for comparison against industry benchmarks, as the valuation snapshot lacks computed ratios such as ROIC or EBITDA margins. This absence limits the ability to evaluate the company's performance relative to its peers in the personal products industry. Segment and geographic exposure data are not disclosed in the available financial reports, making it difficult to assess revenue concentration or regional dependencies. Without this information, the company's exposure to market-specific risks remains opaque. Growth trajectory is also unclear, as the outlook for the current and next fiscal years lacks numeric deltas or directional guidance. The absence of revenue history further complicates the assessment of historical performance trends. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Dilution risk is currently low, as no dilutive instruments are outstanding. Recent events, including filings and transcripts, are not disclosed in the available data, limiting insight into management commentary or strategic shifts.

30-day price · GRG1L.VL-0.07 (-6.3%)
Low$1.02High$1.12Close$1.03As of28 May, 00:00 UTC
Profile
CompanyGrigeo Group AB
TickerGRG1L.VL
SectorConsumer Non-Cyclicals
BusinessPersonal & Household Products & Services
Industry groupPersonal & Household Products & Services
IndustryPersonal Products
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Grigeo Group AB has a fully diluted share count of 132,820,000, matching its basic share count, indicating no dilution from stock options or convertible instruments. However, liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for comparison against industry benchmarks, as the valuation snapshot lacks computed ratios such as ROIC or EBITDA margins. This absence limits the ability to evaluate the company's performance relative to its peers in the personal products industry. Segment and geographic exposure data are not disclosed in the available financial reports, making it difficult to assess revenue concentration or regional dependencies. Without this information, the company's exposure to market-specific risks remains opaque. Growth trajectory is also unclear, as the outlook for the current and next fiscal years lacks numeric deltas or directional guidance. The absence of revenue history further complicates the assessment of historical performance trends. Risk factors include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. Dilution risk is currently low, as no dilutive instruments are outstanding. Recent events, including filings and transcripts, are not disclosed in the available data, limiting insight into management commentary or strategic shifts.
Key takeaways
  • Grigeo Group AB operates in the personal products industry with a fully diluted share count of 132,820,000.
  • Liquidity risk cannot be assessed due to missing balance-sheet inputs and no going-concern language.
  • Profitability and return metrics are not available for comparison with industry benchmarks.
  • Revenue concentration and geographic exposure are not disclosed in the available data.
  • Growth trajectory and historical performance trends are unclear due to missing outlook and revenue history data.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Personal Products · cohort 185 companies
MetricGRG1L.VLActivity
Op margin6.0% medp25 0.5% · p75 12.6%
Net margin5.2% medp25 0.5% · p75 10.9%
Gross margin43.2% medp25 26.0% · p75 61.0%
R&D / revenue1.8% medp25 1.8% · p75 1.8%
CapEx / revenue-3.0% medp25 -5.5% · p75 -1.3%
Debt / equity13.3% medp25 2.5% · p75 55.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 02:05 UTC#69d4ad06
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 01:42 UTCJob: 6dc625e0